Relief Competitors

Delisted . USA . 
Stock . Relief Therapeutics Holding
Relief Therapeutics competes with Vacasa, NL Industries, Paysafe, Alto Ingredients, and Park Electrochemical; as well as few others. Analyzing Relief Therapeutics competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Relief Therapeutics to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in census.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Relief Therapeutics competition on your existing holdings.
  
Specify up to 10 symbols:
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Relief Therapeutics. Your research has to be compared to or analyzed against Relief Therapeutics' peers to derive any actionable benefits. When done correctly, Relief Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Relief Therapeutics.

Relief Therapeutics Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Relief Therapeutics and its competitors represents the degree of relationship between the price movements of corresponding otcs. A correlation of about +1.0 implies that the price of Relief and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Relief Therapeutics does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
PKE
+ 0.73
NL
BNTX
+ 0.6
PKE
BNTX
+ 0.58
PSFE
NTGR
+ 0.51
PSFE
PKE
+ 0.46
PSFE
NTGR
+ 0.42
PKE
  
High negative correlations   
NL
- 0.63
VCSA
PKE
- 0.27
VCSA
AIHS
- 0.03
PSFE
PSFE
- 0.03
NL
AIHS
- 0.01
VCSA

Risk-Adjusted Indicators

There is a big difference between Relief OTC Stock performing well and Relief Therapeutics OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Relief Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Relief Therapeutics Competitive Analysis

The better you understand Relief Therapeutics competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Relief Therapeutics' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Relief Therapeutics' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
VCSA NL PSFE ALTO PKE BNTX NTGR AIHS
 2.55 
 5.23 
Vacasa
 5.53 
 7.82 
NL Industries
 3.88 
 15.81 
Paysafe
 5.04 
 1.32 
Alto
 1.13 
 13.46 
Park
 2.05 
 99.47 
BioNTech
 1.10 
 23.90 
NETGEAR
 1.15 
 0.86 
Senmiao
Market Volatility
(90 Days Market Risk)
Unstable
Slightly risky
Not too volatile
Very risky
Very steady
Very steady
Not too volatile
Extremely Dangerous
Market Performance
(90 Days Performance)
OK
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Quite High
Very Low
Very Small
Average
Very Low
Low
Low
Below Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Under Valued
Under Valued
Under Valued
Under Valued
Fairly Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Hold
Hold
Hold
Strong Buy
Strong Sell
Strong Buy
Buy
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Cautious Hold
Hold
Hold
Strong Hold
Strong Hold
Sell
Strong Hold
Strong Sell
Current Ratio
0.88 X
6.63 X
1.06 X
2.88 X
17.40 X
5.15 X
2.51 X
1.12 X
Net Asset
663.55 M
578.26 M
4.81 B
454.24 M
132.31 M
22.53 B
850.23 M
9.86 M
Profit Margin
(0.10) %
0.46 %
0.01 %
(0.06) %
0.12 %
(0.24) %
0.02 %
(0.57) %
EBITDA
(426.87 M)
87.54 M
429.58 M
(51.67 M)
9.89 M
(367.1 M)
(65.8 M)
(3.01 M)
Operating Margin
0.19 %
(0.04) %
0.07 %
(0.04) %
0.13 %
0.12 %
(0.06) %
(0.77) %
Current Valuation
86.46 M
198.33 M
3.1 B
180.27 M
200.71 M
5.35 B
326.35 M
8.57 M
Price To Book
0.80 X
0.91 X
1.04 X
0.45 X
2.52 X
1.10 X
1.30 X
76.00 X
Retained Earnings
(1.24 B)
315.06 M
(2.24 B)
(763.91 M)
(45.37 M)
19.1 B
(457.12 M)
(41.38 M)
Current Asset
N/A
124.76 M
N/A
N/A
272.19 M
284.67 M
821.14 M
14.81 M
Five Year Return
N/A
N/A
N/A
N/A
2.72 %
N/A
N/A
N/A
Beta
0.74
0.55
1.88
1.74
0.41
0.31
0.72
0.62
Number Of Employees
6.4 K
3.03 K
3.3 K
N/A
123
N/A
655
55
Shares Outstanding
15.73 M
48.85 M
59.89 M
76.56 M
19.93 M
239.97 M
28.87 M
10.52 M
Cash Flow From Operations
(51.71 M)
25.57 M
253.8 M
22.02 M
4.41 M
207.7 M
164.8 M
7.24 K
Annual Yield
N/A
0.05 %
N/A
N/A
0.04 %
N/A
N/A
N/A
Total Debt
25.87 M
500 K
2.41 B
105.46 M
135 K
254.2 M
19.8 M
718.62 K
Return On Equity
-0.86
0.17
0.0252
-0.23
0.0666
-0.0336
0.023
-0.85
Return On Asset
-0.0677
0.0204
0.0171
-0.0292
0.0481
-0.0361
-0.0533
-0.25
Number Of Shares Shorted
697.85 K
74.57 K
1.22 M
687.04 K
223.41 K
3.02 M
1.19 M
298.84 K
Book Value Per Share
6.40 X
8.12 X
14.68 X
2.94 X
5.39 X
80.89 X
18.98 X
(0.11) X
Current Liabilities
N/A
24.01 M
N/A
N/A
16.68 M
143.37 M
315.77 M
3.03 M
Total Asset
663.55 M
578.26 M
4.81 B
454.24 M
132.31 M
22.53 B
850.23 M
9.86 M
Debt To Equity
0.03 %
0 %
2.96 %
0.18 %
0 %
0.01 %
0.05 %
0.09 %
Short Ratio
3.51 X
2.54 X
3.02 X
1.47 X
4.15 X
3.62 X
2.68 X
25.54 X
Target Price
2.5
6.0
18.17
4.5
26.0
139.9
29.0
N/A
Last Dividend Paid
N/A
0.32
N/A
N/A
0.5
N/A
N/A
N/A
Shares Owned By Institutions
71.70 %
12.58 %
58.83 %
41.55 %
79.40 %
22.00 %
93.28 %
0.08 %
Market Capitalization
116.29 M
361.96 M
911.5 M
101.07 M
265.2 M
23.39 B
682.46 M
9.05 M
Price To Earning
1.63 X
22.67 X
N/A
7.22 X
45.43 X
5.19 X
7.07 X
(11.83) X
Price To Earnings To Growth
N/A
(0.42) X
N/A
0.61 X
2.36 X
0.04 X
2.84 X
N/A
Price To Sales
0.12 X
2.48 X
0.53 X
0.10 X
4.32 X
8.50 X
1.01 X
1.54 X
Net Income
(298.7 M)
69.26 M
22.16 M
(28 M)
7.47 M
(677.7 M)
12.36 M
(3.67 M)
Earnings Per Share
(7.02) X
1.38 X
0.36 X
(0.82) X
0.36 X
(3.00) X
0.42 X
(0.35) X
Shares Owned By Insiders
15.18 %
83.00 %
24.44 %
6.62 %
9.49 %
63.22 %
6.91 %
11.12 %
Revenue
1.12 B
145.94 M
1.7 B
965.26 M
56 M
2.75 B
673.76 M
6.81 M
Working Capital
(156.98 M)
146.9 M
231.06 M
103.48 M
89.19 M
16.28 B
487.95 M
(2.69 M)
Cash And Equivalents
319.25 M
68.87 M
220.19 M
57.38 M
4.24 M
9.33 B
233.2 M
2.54 M
Cash Per Share
1.41 X
3.10 X
0.30 X
0.77 X
5.01 X
38.30 X
8.07 X
0.33 X
Gross Profit
495.95 M
41.36 M
989.07 M
9.72 M
17.14 M
2.21 B
195.93 M
1.35 M
Day Typical Price
5.2
7.7
15.79
1.34
13.47
99.04
23.97
0.87
Accumulation Distribution
6602.05
1340.42
17024.51
0.0786
503.76
12092.61
8611.14
29.38
Market Facilitation Index
0.0
0.0
0.0
0.11
0.0
0.0
0.0
1.0E-4
Daily Balance Of Power
0.8667
0.7885
0.8676
(0.64)
0.4688
1.136364
0.4063
(0.25)
Period Momentum Indicator
0.13
0.41
0.59
(0.07)
0.15
2.0
0.26
(0.01)
Rate Of Daily Change
1.03
1.06
1.04
0.95
1.01
1.02
1.01
0.99
Day Median Price
5.19
7.64
15.78
1.35
13.47
98.82
24.01
0.88
Price Action Indicator
0.11
0.39
0.33
(0.06)
0.065
1.65
0.02
(0.03)
Coefficient Of Variation
1168.94
(2,958)
(1,480)
(5,451)
(1,159)
(1,270)
(4,121)
2602213.09
Mean Deviation
2.32
2.32
2.58
3.16
1.31
2.49
2.22
2.57
Jensen Alpha
0.4307
0.0717
(0.05)
0.0508
(0.04)
(0.13)
0.0551
(0.05)
Total Risk Alpha
1.2
0.4186
0.439
0.621
0.1295
0.2755
0.3929
0.6231
Sortino Ratio
0.1698
N/A
N/A
N/A
N/A
N/A
N/A
0.0313
Downside Variance
10.12
N/A
N/A
N/A
N/A
N/A
N/A
17.9
Standard Deviation
4.77
3.18
4.45
4.2
1.7
3.18
2.79
3.76
Kurtosis
16.4
0.5872
8.8
0.3279
0.4437
0.5816
(0.21)
2.64
Potential Upside
5.69
6.24
3.72
8.33
2.2
4.75
4.41
5.68
Treynor Ratio
1.72
(0.09)
(0.17)
(0.09)
(0.19)
(0.29)
(0.08)
0.0335
Maximum Drawdown
31.66
13.99
35.03
19.74
7.97
16.34
12.12
23.64
Variance
22.73
10.12
19.78
17.66
2.88
10.11
7.8
14.11
Market Risk Adjusted Performance
1.73
(0.08)
(0.16)
(0.08)
(0.18)
(0.28)
(0.07)
0.0435
Risk Adjusted Performance
0.0804
(0.02)
(0.05)
(0.01)
(0.07)
(0.06)
(0.01)
0.0078
Skewness
3.2
0.4892
(1.09)
0.5807
0.0237
0.4075
(0.18)
0.4154
Semi Deviation
2.39
N/A
N/A
N/A
N/A
N/A
N/A
3.32
Information Ratio
0.1133
0.0078
(0.04)
0.0131
(0.01)
(0.04)
0.0231
0.0352
Value At Risk
(5.88)
(5.94)
(5.69)
(6.00)
(2.98)
(5.12)
(5.11)
(6.54)
Expected Short fall
(3.20)
N/A
N/A
N/A
N/A
N/A
N/A
(3.26)
Downside Deviation
3.18
N/A
N/A
N/A
N/A
N/A
N/A
4.23
Semi Variance
5.72
N/A
N/A
N/A
N/A
N/A
N/A
11.02

Relief Therapeutics Competition Performance Charts

Five steps to successful analysis of Relief Therapeutics Competition

Relief Therapeutics' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Relief Therapeutics in relation to its competition. Relief Therapeutics' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Relief Therapeutics in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Relief Therapeutics' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Relief Therapeutics, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Relief Therapeutics position

In addition to having Relief Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Natural Foods Thematic Idea Now

Natural Foods
Natural Foods Theme
Companies producing natural foods including dairy products and different types of meets. The Natural Foods theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Natural Foods Theme or any other thematic opportunities.
View All  Next Launch
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in census.
Note that the Relief Therapeutics information on this page should be used as a complementary analysis to other Relief Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Consideration for investing in Relief OTC Stock

If you are still planning to invest in Relief Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Relief Therapeutics' history and understand the potential risks before investing.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Stocks Directory
Find actively traded stocks across global markets
Global Correlations
Find global opportunities by holding instruments from different markets
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY